Lexeo Therapeutics, Inc. Common Stock
LXEO
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$5.84
FAIR PRICE
$3.01
MARGIN
$2.83
P/E Ratio
N/A
Div. Yield
N/A
ROE
-90.5%
Average
Market Cap
$419M
Small-cap
COMING SOON
Get notified when LXEO's fair price changes
Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.
iOS and Android · Free tier available
KEY FACTS
CEO
R. Nolan Townsend
COUNTRY
US
HEADQUARTERS
New York City
SECTOR
Healthcare
EXCHANGE
NASDAQ
METHODOLOGY
How we calculate LXEO's fair price
Lexeo Therapeutics, Inc. Common Stock's fair price of $3.01 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $5.84, LXEO trades 48.5% above its calculated fair value.
DCF MODEL · 50%
Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting LXEO's risk profile.
RELATIVE · 30%
Comparing LXEO's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.
ANALYST · 20%
Aggregated analyst price targets for LXEO, weighted by recency and analyst accuracy.
TRY IT YOURSELF
Want to test your own assumptions? Use our free calculators to estimate LXEO's fair value with your own inputs.
LEARN MORE
POWERED BY BULIOS
Get full analysis, financials, and AI insights for LXEO.
Explore on BuliosFAQ
What is the fair price of LXEO?+
Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Lexeo Therapeutics, Inc. Common Stock is $3.01. At the current market price of $5.84, LXEO trades 48.5% above its calculated fair value.
Is LXEO overvalued or undervalued?+
Lexeo Therapeutics, Inc. Common Stock is currently overvalued based on our valuation model. The stock trades at $5.84, which is 48.5% above the fair price of $3.01.
How often is LXEO's fair price updated?+
We update fair price calculations for LXEO daily after market close. The current fair price of $3.01 incorporates the latest market data and sector multiples.
What factors affect LXEO's fair price calculation?+
LXEO's fair price of $3.01 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight)., ROE of -90.5%.
Is LXEO a good buy right now?+
At $5.84, LXEO trades 48.5% above our fair value estimate of $3.01. The stock is currently overvalued. ROE stands at -90.5% (average). Fair Price Index provides valuation data — always do your own research before investing.
Does LXEO pay dividends?+
LXEO does not currently pay a dividend.
RELATED STOCKS
Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.